EXACT SCIENCES CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 14 rows in 2016. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2016-12-05: Reporting owner LIDGARD GRAHAM PETER; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2016-11-15: Reporting owner Conroy Kevin T; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2016-11-11: Reporting owner LIDGARD GRAHAM PETER; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2016-11-11: Reporting owner Conroy Kevin T; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2016-12-05 | LIDGARD GRAHAM PETER Officer (Chief Science Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −63,888 0 owned after | $2.88 exercise price | 2016-12-06 | |
| 2016-11-15 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −33,075 94,425 owned after | $9.07 exercise price | 2016-11-15 | |
| 2016-11-11 | LIDGARD GRAHAM PETER Officer (Chief Science Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −311,112 63,888 owned after | $2.88 exercise price | 2016-11-15 | |
| 2016-11-11 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −600,000 1,018,076 owned after | $0.83 exercise price | 2016-11-15 | |
| 2016-11-11 | ARORA MANEESH Director, Officer (COO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −562,932 0 owned after | $0.83 exercise price | 2016-11-15 | |
| 2016-06-24 | ARORA MANEESH Director, Officer (COO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −154,568 562,932 owned after | $0.83 exercise price | 2016-06-27 | |
| 2016-06-22 | ARORA MANEESH Director, Officer (COO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −90,000 717,500 owned after | $0.83 exercise price | 2016-06-23 | |
| 2016-02-26 | COWARD D SCOTT Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +55,000 55,000 owned after | $5.70 exercise price | 2016-03-11 | |
| 2016-02-26 | LIDGARD GRAHAM PETER Officer (Chief Science Officer) | 4/A | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +55,000 55,000 owned after | $5.70 exercise price | 2016-03-11 | |
| 2016-02-26 | ARORA MANEESH Director, Officer (COO) | 4/A | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $5.70 exercise price | 2016-03-11 | |
| 2016-02-26 | Conroy Kevin T Director, Officer (President and CEO) | 4/A | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +247,300 247,300 owned after | $5.70 exercise price | 2016-03-11 | |
| 2016-01-25 | Fallon John A. Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +84,589 84,589 owned after | $6.30 exercise price | 2016-01-27 | |
| 2016-01-21 | ARORA MANEESH Director, Officer (COO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −65,000 807,500 owned after | $0.83 exercise price | 2016-01-25 | |
| 2016-01-11 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −265,924 1,618,076 owned after | $0.83 exercise price | 2016-01-13 |